Emmanuelle Clerisme Beaty, MD, MHS, is a senior physician executive and the US Head of Medicine & Regulatory Affairs at Boehringer Ingelheim, where she leads medical strategy, evidence generation, and regulatory oversight across a broad portfolio. Across more than 15 years in global drug development and medical affairs, Emmanuelle has guided breakthrough designations, first in class launches, and cross functional initiatives that advance innovative therapies for patients with high unmet need. In her current role, she advances an innovative, fast evolving cardio renal metabolic portfolio, guided by integrated science, a unified therapeutic strategy, and a commitment to improving outcomes for over one billion people living with CRM conditions.